<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134625</url>
  </required_header>
  <id_info>
    <org_study_id>1606-069-771</org_study_id>
    <nct_id>NCT03134625</nct_id>
  </id_info>
  <brief_title>Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation</brief_title>
  <official_title>Identification of Metabolite Biomarkers Related to Acute Rejection of Patients With Kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      The development of acute rejection can only be considered in cases with increasing serum&#xD;
      creatinine in patients with kidney transplantation. However, the serum creatinine itself is&#xD;
      not specific but also accurate for detection of acute rejection. So The specific biomarker is&#xD;
      required for acute rejection of kidney transplant. In this study, the investigators will&#xD;
      enroll 200 consecutive kidney transplant patients in Seoul National University Hospital and&#xD;
      follow up. Serial collection of urine and serum will be done. Acute rejection specific urine&#xD;
      metabolite will be found by LC MS/MS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 28, 2016</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>biomarker for acute rejection in kidney transplantation</measure>
    <time_frame>1 year</time_frame>
    <description>urine metabolite which is specific for kidney transplant rejection</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>Rejection Acute Renal</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population includes low or moderate risk kidney transplantation. They should have&#xD;
        triple immunosuppression.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Kidney transplant patients in Seoul National University Hospital&#xD;
&#xD;
          -  Patients with triple maintenance immunosuppression including Tacrolimus, mycophenolate&#xD;
             and steroid&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of other organ transplantation&#xD;
&#xD;
          -  ABOi and/or crossmatch(+) transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jongwon Ha, MD, PhD</last_name>
    <phone>+82-2-2072-2991</phone>
    <email>jwhamd@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jongwon Ha, MD, PhD</last_name>
      <phone>+82-2-2072-2991</phone>
      <email>jwhamd@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>April 21, 2019</last_update_submitted>
  <last_update_submitted_qc>April 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolomics</keyword>
  <keyword>biomarker</keyword>
  <keyword>acute rejection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

